| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Updated response assessment criteria for high-grade gliomas: response assessment in neuro-oncology working group.
|
J Clin Oncol
|
2010
|
14.79
|
|
2
|
A randomized trial of bevacizumab for newly diagnosed glioblastoma.
|
N Engl J Med
|
2014
|
9.19
|
|
3
|
Inhibition of constitutively active Stat3 suppresses proliferation and induces apoptosis in glioblastoma multiforme cells.
|
Oncogene
|
2002
|
2.69
|
|
4
|
Myeloid-derived suppressor cell accumulation and function in patients with newly diagnosed glioblastoma.
|
Neuro Oncol
|
2011
|
2.13
|
|
5
|
End point assessment in gliomas: novel treatments limit usefulness of classical Macdonald's Criteria.
|
J Clin Oncol
|
2009
|
2.13
|
|
6
|
The importance of the conformality, heterogeneity, and gradient indices in evaluating Gamma Knife radiosurgery treatment plans for intracranial meningiomas.
|
Int J Radiat Oncol Biol Phys
|
2011
|
2.03
|
|
7
|
Treatment outcomes for patients with glioblastoma multiforme and a low Karnofsky Performance Scale score on presentation to a tertiary care institution. Clinical article.
|
J Neurosurg
|
2011
|
1.70
|
|
8
|
Poor drug distribution as a possible explanation for the results of the PRECISE trial.
|
J Neurosurg
|
2010
|
1.65
|
|
9
|
Serum S100beta: a noninvasive marker of blood-brain barrier function and brain lesions.
|
Cancer
|
2003
|
1.50
|
|
10
|
Phase II trial of erlotinib with temozolomide and radiation in patients with newly diagnosed glioblastoma multiforme.
|
J Neurooncol
|
2009
|
1.48
|
|
11
|
Results of a phase II trial of the GliaSite radiation therapy system for the treatment of newly diagnosed, resected single brain metastases.
|
J Neurosurg
|
2006
|
1.47
|
|
12
|
Clinical trial end points for high-grade glioma: the evolving landscape.
|
Neuro Oncol
|
2011
|
1.42
|
|
13
|
A nomogram for individualized estimation of survival among patients with brain metastasis.
|
Neuro Oncol
|
2012
|
1.32
|
|
14
|
Aberrant constitutive activation of nuclear factor kappaB in glioblastoma multiforme drives invasive phenotype.
|
J Neurooncol
|
2007
|
1.22
|
|
15
|
Novel drug delivery strategies in neuro-oncology.
|
Neurotherapeutics
|
2009
|
1.21
|
|
16
|
Function of the blood-brain barrier and restriction of drug delivery to invasive glioma cells: findings in an orthotopic rat xenograft model of glioma.
|
Drug Metab Dispos
|
2012
|
1.19
|
|
17
|
Aggressive treatment is appropriate for glioblastoma multiforme patients 70 years old or older: a retrospective review of 206 cases.
|
Neuro Oncol
|
2011
|
1.17
|
|
18
|
IL-13R(alpha)2, a decoy receptor for IL-13 acts as an inhibitor of IL-4-dependent signal transduction in glioblastoma cells.
|
Cancer Res
|
2002
|
1.15
|
|
19
|
Residual tumor volume versus extent of resection: predictors of survival after surgery for glioblastoma.
|
J Neurosurg
|
2014
|
1.15
|
|
20
|
Stereotactic radiosurgery for single brainstem metastases: the cleveland clinic experience.
|
Int J Radiat Oncol Biol Phys
|
2010
|
1.14
|
|
21
|
Treatment of five or more brain metastases with stereotactic radiosurgery.
|
Int J Radiat Oncol Biol Phys
|
2011
|
1.14
|
|
22
|
Intracranial meningiomas of atypical (WHO grade II) histology.
|
J Neurooncol
|
2010
|
1.14
|
|
23
|
Quantum dots are phagocytized by macrophages and colocalize with experimental gliomas.
|
Neurosurgery
|
2007
|
1.12
|
|
24
|
PTPmu suppresses glioma cell migration and dispersal.
|
Neuro Oncol
|
2009
|
1.12
|
|
25
|
Recursive partitioning analysis of prognostic factors for glioblastoma patients aged 70 years or older.
|
Cancer
|
2012
|
1.08
|
|
26
|
Brain metastases.
|
Curr Probl Surg
|
2004
|
1.07
|
|
27
|
Aberrant Stat3 signaling by interleukin-4 in malignant glioma cells: involvement of IL-13Ralpha2.
|
Cancer Res
|
2005
|
1.07
|
|
28
|
Five-year survivors of brain metastases: a single-institution report of 32 patients.
|
Int J Radiat Oncol Biol Phys
|
2006
|
1.07
|
|
29
|
In touch with robotics: neurosurgery for the future.
|
Neurosurgery
|
2005
|
1.07
|
|
30
|
Conventional MRI does not reliably distinguish radiation necrosis from tumor recurrence after stereotactic radiosurgery.
|
J Neurooncol
|
2012
|
1.07
|
|
31
|
Salvage stereotactic radiosurgery effectively treats recurrences from whole-brain radiation therapy.
|
Cancer
|
2008
|
1.06
|
|
32
|
Brain metastases from esophageal cancer: a phenomenon of adjuvant therapy?
|
Ann Thorac Surg
|
2006
|
1.04
|
|
33
|
Long-term experience with World Health Organization grade III (malignant) meningiomas at a single institution.
|
Int J Radiat Oncol Biol Phys
|
2009
|
1.04
|
|
34
|
Use of the Radiation Therapy Oncology Group recursive partitioning analysis classification system and predictors of survival in 19 women with brain metastases from ovarian carcinoma.
|
Cancer
|
2005
|
1.04
|
|
35
|
Challenges relating to solid tumour brain metastases in clinical trials, part 2: neurocognitive, neurological, and quality-of-life outcomes. A report from the RANO group.
|
Lancet Oncol
|
2013
|
1.03
|
|
36
|
Challenges relating to solid tumour brain metastases in clinical trials, part 1: patient population, response, and progression. A report from the RANO group.
|
Lancet Oncol
|
2013
|
1.03
|
|
37
|
IL-8 is a mediator of NF-κB induced invasion by gliomas.
|
J Neurooncol
|
2010
|
1.01
|
|
38
|
RPA classification has prognostic significance for surgically resected single brain metastasis.
|
Int J Radiat Oncol Biol Phys
|
2006
|
0.99
|
|
39
|
Histidine-rich glycoprotein modulates the anti-angiogenic effects of vasculostatin.
|
Am J Pathol
|
2010
|
0.97
|
|
40
|
Multidisciplinary management of colorectal brain metastases: a retrospective study.
|
Cancer
|
2008
|
0.96
|
|
41
|
Molecular targeted therapy in recurrent glioblastoma: current challenges and future directions.
|
Expert Opin Investig Drugs
|
2012
|
0.95
|
|
42
|
Future of convection-enhanced delivery in the treatment of brain tumors.
|
Future Oncol
|
2010
|
0.95
|
|
43
|
Epidermal growth factor receptor amplification does not have prognostic significance in patients with glioblastoma multiforme.
|
Int J Radiat Oncol Biol Phys
|
2005
|
0.95
|
|
44
|
p300- and Myc-mediated regulation of glioblastoma multiforme cell differentiation.
|
Oncotarget
|
2010
|
0.93
|
|
45
|
Intracranial collision tumor mimicking an octreotide-SPECT positive and FDG-PET negative meningioma.
|
J Clin Neurosci
|
2005
|
0.93
|
|
46
|
Stereotactic radiosurgery as single-modality treatment of incidentally identified renal cell carcinoma brain metastases.
|
World Neurosurg
|
2009
|
0.92
|
|
47
|
Posterior fossa metastases: risk of leptomeningeal disease when treated with stereotactic radiosurgery compared to surgery.
|
J Neurooncol
|
2004
|
0.91
|
|
48
|
Silencing IL-13Rα2 promotes glioblastoma cell death via endogenous signaling.
|
Mol Cancer Ther
|
2011
|
0.90
|
|
49
|
The impact of genotype on outcome in oligodendroglioma: validation of the loss of chromosome arm 1p as an important factor in clinical decision making.
|
J Neurosurg
|
2006
|
0.90
|
|
50
|
Results of a survey of neurosurgical practice patterns regarding the prophylactic use of anti-epilepsy drugs in patients with brain tumors.
|
J Neurooncol
|
2005
|
0.90
|
|
51
|
The role of 111indium-octreotide brain scintigraphy in the diagnosis of cranial, dural-based meningiomas.
|
J Neurooncol
|
2006
|
0.89
|
|
52
|
Stereotactic radiosurgical treatment of brain metastases in older patients.
|
Cancer
|
2008
|
0.89
|
|
53
|
Effect of imaging and catheter characteristics on clinical outcome for patients in the PRECISE study.
|
J Neurooncol
|
2010
|
0.89
|
|
54
|
Intracranial navigation by using low-field intraoperative magnetic resonance imaging: preliminary experience.
|
J Neurosurg
|
2002
|
0.88
|
|
55
|
Results of a questionnaire regarding practice patterns for the diagnosis and treatment of intracranial radiation necrosis after SRS.
|
J Neurooncol
|
2013
|
0.88
|
|
56
|
Impact of non-small cell lung cancer histology on survival predicted from the graded prognostic assessment for patients with brain metastases.
|
Lung Cancer
|
2012
|
0.87
|
|
57
|
Use of therapeutic drug monitoring to treat Elizabethkingia meningoseptica meningitis and bacteraemia in an adult.
|
J Antimicrob Chemother
|
2012
|
0.87
|
|
58
|
Meningiomas: knowledge base, treatment outcomes, and uncertainties. A RANO review.
|
J Neurosurg
|
2015
|
0.86
|
|
59
|
Myeloid derived suppressor cell infiltration of murine and human gliomas is associated with reduction of tumor infiltrating lymphocytes.
|
J Neurooncol
|
2015
|
0.85
|
|
60
|
Cyclooxygenase-2 (COX-2) expression by immunohistochemistry in glioblastoma multiforme.
|
Ann Diagn Pathol
|
2002
|
0.85
|
|
61
|
Use of high-field intraoperative magnetic resonance imaging to enhance the extent of resection of enhancing and nonenhancing gliomas.
|
Neurosurgery
|
2014
|
0.84
|
|
62
|
Long-term outcomes of Gamma Knife radiosurgery in patients with vestibular schwannomas.
|
J Neurosurg
|
2010
|
0.84
|
|
63
|
Stereotactic radiosurgical treatment of parenchymal brain metastases from prostate adenocarcinoma.
|
Surg Neurol
|
2008
|
0.84
|
|
64
|
Epidermal growth factor receptor antagonists: novel therapy for the treatment of high-grade gliomas.
|
Neurosurgery
|
2004
|
0.83
|
|
65
|
Gender, race, and survival: a study in non-small-cell lung cancer brain metastases patients utilizing the radiation therapy oncology group recursive partitioning analysis classification.
|
Int J Radiat Oncol Biol Phys
|
2009
|
0.82
|
|
66
|
Posterior fossa metastases: aggressive treatment improves survival.
|
Stereotact Funct Neurosurg
|
2003
|
0.80
|
|
67
|
Stereotactic radiosurgical treatment of brain metastases to the choroid plexus.
|
Int J Radiat Oncol Biol Phys
|
2011
|
0.80
|
|
68
|
Role of Gamma Knife surgery in patients with 5 or more brain metastases.
|
J Neurosurg
|
2012
|
0.80
|
|
69
|
Does extent of resection of a glioblastoma matter?
|
Clin Neurosurg
|
2012
|
0.79
|
|
70
|
Impact of preexisting tumor necrosis on the efficacy of stereotactic radiosurgery in the treatment of brain metastases in women with breast cancer.
|
Cancer
|
2011
|
0.79
|
|
71
|
Tumor progression in patients receiving adjuvant whole-brain radiotherapy vs localized radiotherapy after surgical resection of brain metastases.
|
Neurosurgery
|
2015
|
0.79
|
|
72
|
Cyclooxygenase-2 in oligodendroglial neoplasms.
|
Cancer
|
2003
|
0.79
|
|
73
|
Prospective study of the short-term adverse effects of gamma knife radiosurgery.
|
Technol Cancer Res Treat
|
2012
|
0.78
|
|
74
|
Using higher isodose lines for gamma knife treatment of 1 to 3 brain metastases is safe and effective.
|
Neurosurgery
|
2014
|
0.78
|
|
75
|
Intraoperative radiotherapy to treat newly diagnosed solitary brain metastasis: initial experience and long-term outcomes.
|
J Neurosurg
|
2015
|
0.77
|
|
76
|
Gamma knife stereotactic radiosurgery for the management of incidentally-identified brain metastasis from non-small cell lung cancer.
|
J Neurooncol
|
2011
|
0.77
|
|
77
|
Thin layer chromatography-based assay of O6-methylguanine-DNA methyltransferase activity in tissue.
|
Anal Biochem
|
2010
|
0.77
|
|
78
|
331 Association Between Radiation Necrosis and Tumor Biology Following Stereotactic Radiosurgery for Brain Metastasis.
|
Neurosurgery
|
2016
|
0.76
|
|
79
|
Current Management and Treatment Modalities for Intramedullary Spinal Cord Tumors.
|
Curr Treat Options Oncol
|
2015
|
0.76
|
|
80
|
Is there a shortage of neurosurgeons in the United States?
|
Neurosurgery
|
2013
|
0.76
|
|
81
|
Management of brain metastases.
|
Curr Neurol Neurosci Rep
|
2009
|
0.76
|
|
82
|
Update of stereotactic radiosurgery for brain tumors.
|
Curr Opin Neurol
|
2004
|
0.76
|
|
83
|
Ridaforolimus for patients with progressive or recurrent malignant glioma: a perisurgical, sequential, ascending-dose trial.
|
Cancer Chemother Pharmacol
|
2011
|
0.76
|
|
84
|
Relationship between HER2 status and prognosis in women with brain metastases from breast cancer.
|
Int J Radiat Oncol Biol Phys
|
2011
|
0.76
|
|
85
|
Phase II trial of ritonavir/lopinavir in patients with progressive or recurrent high-grade gliomas.
|
J Neurooncol
|
2010
|
0.75
|
|
86
|
Caspase-9 transduction overrides the resistance mechanism against p53-mediated apoptosis in U87MG glioma cells.
|
Neurosurgery
|
2002
|
0.75
|
|
87
|
Imaging characteristics of zinc sulfide shell, cadmium telluride core quantum dots.
|
Nanomedicine (Lond)
|
2008
|
0.75
|
|
88
|
895 Desferoxamine Protects T Cells from Glioblastoma Multiforme-mediated Apoptosis and Improves Cytolytic Activity of T Cells in Killing of Tumor Targets.
|
Neurosurgery
|
2005
|
0.75
|
|
89
|
Mapping prosody: correlation of functional magnetic resonance imaging with intraoperative electrocorticography recordings in a patient with a right-sided temporooccipital glioma. Case illustration.
|
J Neurosurg
|
2005
|
0.75
|